Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04669418Completed

Host RNA Signature in Children With Cancer and Infection

Role: collaborator

NCT03402425Not ApplicableUnknown

The Diagnostic Value of 18F-FET PET/MRI for CNS Tumors in Children and Adolescents

Role: collaborator

NCT02583139Not ApplicableUnknown

Designed Music Narratives for the Reduction of Side Effects of Chemotherapy in Children (7-12 Years) With Cancer

Role: collaborator

NCT02583126Not ApplicableUnknown

Guided Imagery and Music for the Reduction of Side Effects of Chemotherapy in Teenagers

Role: collaborator

All 4 trials loaded